Trial Profile
A Phase II, Non-randomized, Open-label, Single-center Study to Evaluate the Efficacy and Safety of Erlotinib in Combination With Cisplatin based Chemoradiotherapy in Patients with Locally Advanced Cervical Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2015
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Therapeutic Use
- 10 Nov 2015 New trial record